Workflow
Windtree Therapeutics Announces Closing of Financing Through a Private Placement of Series C Preferred Stock
WINTWindtree Therapeutics(WINT) Newsfilter·2024-07-22 20:05

12.9MillionTransactionIncludesApproximately12.9 Million Transaction Includes Approximately 3.4 Million of New Funding and a 9.5MillionFullCancellationofOutstandingSeniorNotesandExtinguishmentofSeriesBPreferredSharesTheCompanyAlsoEstablisheda9.5 Million Full Cancellation of Outstanding Senior Notes and Extinguishment of Series B Preferred Shares The Company Also Established a 35 Million Equity Line of Credit WARRINGTON, Pa., July 22, 2024 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. ("Windtree" or "the Company") (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases, today ...